Medicare Enrolled
Dr. Nedim Ruhotina, M.D.
Urology Physician · Liverpool, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ruhotina from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ruhotina?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ruhotina
Dr. Nedim Ruhotina is an urology physician in Liverpool, NY, with 15 years of NPI registration. Based on federal Medicare data, Dr. Ruhotina performed 10,588 Medicare services across 1,845 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ruhotina received a total of $68,290 from 51 pharmaceutical and/or device companies across 367 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ruhotina is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 8% volume in NY
$68,290 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,588
Medicare services
Top 8% in NY for urology physician
1,845
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~706 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,540 | $17 | $42 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,800 | $0 | $2 |
| BCG treatment for bladder cancer | 1,900 | $2 | $6 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
485 | $2 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
328 | $88 | $265 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
250 | $8 | $11 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
177 | $57 | $180 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
117 | $46 | $124 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 106 | $117 | $1,500 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
98 | $7 | $46 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
74 | $54 | $184 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
69 | $21 | $130 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
69 | $37 | $90 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
54 | $182 | $730 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
46 | $67 | $215 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
45 | $24 | $79 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
39 | $181 | $960 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
38 | $105 | $405 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $117 | $400 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
31 | $11 | $62 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
31 | $34 | $94 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
29 | $16 | $216 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
25 | $43 | $153 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
24 | $194 | $675 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $136 | $355 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
22 | $62 | $334 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
21 | $2,243 | $8,445 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
18 | $157 | $455 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
18 | $5 | $81 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
18 | $87 | $236 |
| Simple change of bladder tube | 17 | $74 | $222 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
17 | $73 | $271 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $60 | $183 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow within the bladder to evaluate how well the bladder and urethra are functioning. |
11 | $137 | $719 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$68,290
Total received (2018-2024)
Avg $9,756/year across 7 years
Top 5% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
367
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$38,892 (57.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22,091 (32.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,307 (10.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$27,331
2023
$33,529
2022
$4,648
2021
$611
2020
$310
2019
$802
2018
$1,060
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$21,583
Janssen Scientific Affairs, LLC
$2,990
Janssen Biotech, Inc.
$1,302
Axonics, Inc.
$405
Dendreon Pharmaceuticals LLC
$322
IMMUNITYBIO, INC.
$177
COLOPLAST CORP
$149
Astellas Pharma US Inc
$110
Novartis Pharmaceuticals Corporation
$60
ABBVIE INC.
$58
Sumitomo Pharma America, Inc.
$51
Merck Sharp & Dohme LLC
$46
Ferring Pharmaceuticals Inc.
$38
Tolmar, Inc.
$23
PFIZER INC.
$18
Top 3 companies account for 94.7% of 2024 payments
All-time payments by company (2018-2024) ›
PALETTE LIFE SCIENCES, INC.
$26,880
Teleflex LLC
$21,858
Bayer Healthcare Pharmaceuticals Inc.
$4,530
Janssen Scientific Affairs, LLC
$3,811
Palette Life Sciences, Inc.
$2,444
Janssen Biotech, Inc.
$1,816
Astellas Pharma US Inc
$1,449
Dendreon Pharmaceuticals LLC
$1,033
Axonics, Inc.
$543
Endocare, Inc.
$478
Bayer HealthCare Pharmaceuticals Inc.
$333
PFIZER INC.
$282
AstraZeneca Pharmaceuticals LP
$245
Ferring Pharmaceuticals Inc.
$198
Sumitomo Pharma America, Inc.
$189
IMMUNITYBIO, INC.
$177
Coloplast Corp
$163
COLOPLAST CORP
$149
Medtronic, Inc.
$149
Boston Scientific Corporation
$142
UroGen Pharma, Inc.
$113
NeoTract Inc.
$109
TOLMAR Pharmaceuticals, Inc.
$108
ACCORD HEALTHCARE, INC.
$106
UROVANT SCIENCES INC
$88
Merck Sharp & Dohme LLC
$85
180 Medical, Inc.
$80
AbbVie Inc.
$67
Amgen Inc.
$61
Novartis Pharmaceuticals Corporation
$60
Endo Pharmaceuticals Inc.
$59
ABBVIE INC.
$58
Antares Pharma, Inc.
$55
UROGEN PHARMA, INC.
$50
Olympus America Inc.
$40
AbbVie, Inc.
$34
Laborie Medical Technologies Corp.
$30
Mission Pharmacal Company
$29
Progenics Pharmaceuticals, Inc.
$24
Tolmar, Inc.
$23
Myovant Sciences Inc.
$20
Merck Sharp & Dohme Corporation
$18
Verity Pharmaceuticals Inc.
$18
Myriad Genetic Laboratories, Inc.
$16
Accord Healthcare, Inc.
$15
Clarus Therapeutics Inc.
$14
Avadel Specialty Pharmaceuticals, LLC
$13
Medtronic USA, Inc.
$12
Sun Pharmaceutical Industries Inc.
$12
HealthTronics Mobile Solutions, LLC
$4
NxThera, Inc.
$2
Top 3 companies account for 78.0% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ALTIS · AMS · ANKTIVA · Androgel · Axonics · BALVERSA · BOTOX · Balversa · Bulkamid · CAMCEVI · Coloplast TFL Drive · ELIGARD · ERLEADA · Endocare Cryocare System · Erleada · GEMTESA · GENERAL THERAPIES · GENTLECATH · GentleCath · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PREMARIN · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · Prolia · Rezum · SPEEDICATH · SpaceOAR VUE System - 10mL · TITAN · TOVIAZ · Titan · Trelstar · UROLIFT · Uribel · UroLift · Urocit-K · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (57%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for urology physician in NY.
Geographic Context
Urology physicians within 10 mi
57
Per 100K population
12.1
County median income
$74,740
Nearest hospital
ST JOSEPH'S HOSPITAL HEALTH CENTER
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ruhotina is a mixed practice specialist, with above-average Medicare volume (top 8% in NY), with consulting-driven industry engagement in the top 5% of NY peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ruhotina experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Ruhotina performed 3,540 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ruhotina receive payments from pharmaceutical companies?
Yes. Dr. Ruhotina received a total of $68,290 from 51 companies across 367 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ruhotina's costs compare to other urology physicians in Liverpool?
Dr. Ruhotina's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ruhotina) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Liverpool
Browse urology physicians in Liverpool ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
PALETTE LIFE SCIENCES, INC. Payments to Doctors
See all physicians who received payments from PALETTE LIFE SCIENCES, INC.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology